Current situation of pharmacy services in community health centers and the functioning of pharmacists in family doctor teams in Shanghai^☆

Abstract

Background: Currently, polypharmacy is common among residents at high risk of unsafe medication practices, partly due to a lack of medication reconciliation and comprehensive medication management. Pharmacy services, facilitated by community health centers with regional advantages, align with their functional orientation. However, a significant gap persists between the supply of pharmacy services in community health centers and public demand.
Objective: To assess the current state of pharmacy services and the integration of pharmacists into family doctor teams in Shanghai, as well as to identify the challenges faced by community pharmacists, with the goal of providing recommendations for their development.
Methods: A combination of qualitative and quantitative approach was adopted. In December 2020, a stratified sampling method was employed to survey 307 on-duty pharmacists with licensed pharmacist qualifications from 29 community health centers, including 6 in the central urban areas, 8 in the inner and outer suburban areas, and 15 in the outer suburban areas. The contents of the questionnaire covered basic information about the pharmacists, the development of pharmacy services, and the participation of community pharmacists in the family doctor team. Concurrently, a convenience sampling method was used to invite 29 key stakeholders, including 11 head of pharmacies, 6 family doctors, 12 community health center directors or health commission managers from central urban areas, inner and outer suburban areas, and outer suburban areas, for semi-structured focus interviews on pharmacy service demands, resources allocation, and service processes.
Results: The quantitative results indicated that the most community pharmacists attended 1-2 times of training programs [139 (45.3 %)], with continuing education as the main form of training [252 (82.1 %)]. The most common pharmacy service activities were prescription dispensing [284 (92.5 %)], prescription review [253 (82.4 %)], and pharmacy window advice or outpatient consultation guidance [196 (63.8 %)]. The services consuming the most pharmacist hours were prescription dispensing [280 (91.2 %)], prescription review [244 (79.5 %)], and prescription feedback [145 (47.2 %)]. Only 78 (25.4 %) participants joined family doctor teams. Qualitative results revealed a high demand for pharmacy services among older patients, alongside weak awareness of rational drug use. Challenges included shortage of pharmacist workforce, need for enhanced professional quality, incomplete community pharmacy drug lists, and need for more applying information technology. Furthermore, community pharmacists are often undervalued, with services focusing narrowly on dispensing, insufficient targeted training on rational drug use, and limited functioning within family doctor teams.
Conclusion: Currently, the resources allocation and supply capacity of pharmacy services are inadequate to meet resident demands, and the pharmacy service process requires improvement and optimization. The impact of pharmacists who have joined family doctor teams is limited. Therefore, it is necessary to enhance incentive mechanism, clarify service content and improve the service model.

Keywords

Pharmacy services / Community health center / Family doctor team / Quantitative study / Qualitative study

Declarations

Not applicable.

Authors' contributions

Overall research design, C.Y. and W.H.; Methodology, L.R., C.Y. and C.A.; Data processing, L.R., C.Y. and C.A.; data analysis, L.R., C.Y. and C.A.; Funding acquisition, not applicable; Project administration, not applicable; Resources, not applicable; Supervision, W.H.; Validation, W.H.; Writing—original draft, L.R. and C.A.; Writing—review and editing, W.H. All authors have read and agreed to the published version of the manuscript.

Ethics approval and consent to participate

The study received approval from Shanghai Jinshan District Tinglin Hospital(202011-01).

Consent for publication

Not applicable.

Availability of data and materials

Data used in this study are available upon reasonable request from the corresponding author.

Funding

This research was supported by grants from the Science and Technology Commission of Shanghai Municipality (2020-3-60) and Shanghai Municipal Health Commission (2022HP53).

Competing interests

The authors declare that they have no competing interests

Acknowledgements

Not applicable.

Authors' other information

Not applicable.

References

[1] Yang ZH. Study on the construction of irrational drug intervention system in primary medical institutions. (Chinese). Nanjing: Nanjing University of Chinese Medicine; 2019.

[2] Li L, Li S, Wei Y, et al. Prevalence and factors associated with polypharmacy in community-dwelling older people:a systematic review. (Chinese). Chin Gen Pract. 2021; 24(25):3161-3170. doi: 10.12114/j.issn.1007-9572.2021.00.204.

[3] Wu WH, Zhu J, Cao Y, et al. Current status of the pharmacy workforce in medical institutions in Shanghai. (Chinese). China Health Resources. 2021; 24(5):586-591. doi: 10.3969/j.issn.1007-953X.2021.05.023.

[4] Zhang RY, Peng YC, Zhang ZY. Application Effect and Countermeasures of the Family Contract Service Model Based on "the Consortium of Rural Doctors and Community Doctors" Among the Elderly Residents in the Mountainous Area of North Beijing. (Chinese). Chin Gen Pract. 2022; 25(4):445-452. doi: 10.12114/j.issn.1007-9572.2021.00.262.

[5] Su GB, Qin XD, Zhang L, et al. Facilitators and Barriers to be Physically Active in Patients with Chronic Kidney Disease Based on PEAKING Cohort. (Chinese). Chin Gen Pract. 2020; 23(31):3971-3975. doi: 10.12114/j.issn.1007-9572.2020.00.172.

[6] You CL, Yao M, Qi JG. General Practitioner Trainers’ Perspectives on Continuing Medical Education in General Practice in China:a Qualitative Study. (Chinese). Chin Gen Pract. 2021; 24(34):4364-4371. doi: 10.12114/j.issn.1007-9572.2021.00.302.

[7] Su JF, Wang X, Shi YZ, et al. Analysis of influenza vaccine application policy in China based on the health system macro model. (Chinese). Chin J Prev Med. 2022; 56(7):1023-1026. doi: 10.3760/cma.j.cn112150-20220510-00463.

[8] Zhang Q, Li S, Zhang S, et al. Overview of the international general situation of community pharmaceutical care. (Chinese). Evaluation and Analysis of Drug-Use in Hospitals of China. 2020; 20(1):125-128. doi: 10.14009/j.issn.1672-2124.2020.01.034.

[9] Yu CT. Study on the service ability of Chinese social pharmacy in the perspective of comparison between China and Japan. (Chinese). Nanjing: Nanjing University of Chinese Medicine; 2019.

[10] Gu S, Lai WH, Lin QX, et al. Study on pharmaceutical service fee standards in public hospital in Guangdong Province. (Chinese). Pharmacy Today. 2021; 31(2):147-149.

[11] Chen R, You YZ, Shao ZG, et al. Enlightenment from community pharmacy services in England for domestic pharmacists to manage chronic diseases. (Chinese). Chin J Hos Pharm. 2015; 35(17):1612-1615. doi: 10.13286/j.cnki.

[12] Yin ZC. Research on the reimbursemenrt mechanism of zero-profit drug sales policy for community health care institutions. (Chinese). Tianjin: Tianjin University; 2015.

[13] Tian K, Yu XY, Bai GL, et al. Study on the construction of a primary care pharmaceutical service model based on the family doctor system. (Chinese). J Nanjing Univ Tradit Chin Med (Social Science Edition). 2019; 20(1):39-44.

[14] Wang QD, Zhang SY, Wang WY. The problems and countermeasures in the training and continuing education of clinical pharmacists. (Chinese). Chin J Rational Drug Use. 2017; 14(8):67-70. doi: 10.3969/j.issn.2096-3327.2017.08.019.

[15] Xu J, Chen J, Luo ZL. Practice Analysis and Exploration of the Working Mode of Pharmaceutical Services Alliance. (Chinese). Chin Hos Manag. 2019; 39(1):65-67.

[16] Huang H. Analysis of the current status and problems of pharmaceutical services in the medical consortium of Pudong New Area, Shanghai. (Chinese). Chin Prim Health Care. 2020; 34(4):16-18. doi: 10.3969/j.issn.1001-568X.2020.4.0005.

[17] Cao WL, Ye CL, Liu J, et al. Experience of establishing general pharmacists regulations in the Luohu Hospital Group. (Chinese). Hos Pharm Affairs. 2020; 24(9):56-58. doi: 10.19660/j.issn.1671-0592.2020.09.19.

[18] Anderson C, Bates I, Beck D, et al. The WHO UNESCO FIP pharmacy education taskforce. Hum Resour Health. 2009; 7:45. doi: 10.1186/1478-4491-7-45.

[19] Sun F, Li QB, Cheng SP, et al. Discussion on the current status and optimization measures of community pharmacy services. (Chinese). Strait Pharm J. 2019; 31(12):112-114. doi: 10.3969/j.issn.1006-3765.2019.12.041.

[20] Practice Guidelines for Pharmacotherapy SpecialistsA position statement of the American College of Clinical Pharmacy. The ACCP Clinical Practice Affairs Committee, 1989—1990. Pharmacotherapy. 1990; 10(4):308-311.

[21] Yang Y. Research on design of pharmaceutical service packages in primary medical institutions and implementation strategies. (Chinese). Nanjing: Nanjing University of Chinese Medicine; 2018.

[22] Zhang LL, Zhang Y, Zeng LN, et al. Job responsibilities and career anchor of clinical pharmacists in the United States. (Chinese). China Pharm. 2016; 27(34):4753-4756. doi: 10.6039/j.issn.1001-0408.2016.34.01.

[23] Hasumoto KY, Thomas RK, Yokoi M, et al. Comparison of community pharmacy practice in Japan and US state of Illinois. J Pharm Pract. 2020; 33(1):48-54.

[24] Zhen JC, Lu J, Mei D, et al. Standards for pharmaceutical services in medical institutions. (Chinese). Med Pharm J Chin PLA. 2019; 38(12):1535-1556. doi: 10.3870/j.issn.1004-0781.2019.12.001.

[25] Wu XL, Yu GC. Standards and pathways for family pharmacist services: expert consensus. (Chinese). Guidelines and Consensus. 2018; 15(16):4-16. doi: 10.3969/j.issn.1672-3384.2018.07.001.

[26] Zheng JH, Zeng Z. Community pharmacy services based on the family doctor contract system. (Chinese). J Tradit Chin Med Manag. 2020; 28(8):212-214.

[27] Gong FF, Sun XZ, Cao WL, et al. New mode of community pharmaceutical care promoted by information system. (Chinese). Chin Hosp. 2017; 21(11):19-21. doi: 10.3969/j.issn.1671-0592.2017.11.008.